Healthcare Services Acquisition Corporation

Healthcare Services Acquisition Corporation

HCAR
Healthcare Services Acquisition CorporationUS flagNASDAQ Capital Market
10.10
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
Sector
Financial Services
Industry
Shell Companies
Address
7809 Woodmont Avenue Bethesda MD United States of America 20814
IPO Date
Jan 5, 2021
Business
Healthcare Services Acquisition Corporation (HCAR) operates as a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting technology-enabled healthcare services companies in the United States. The company, founded in 2020 and headquartered in Bethesda, Maryland, has not commenced significant operations or generated revenue, as its activities center on identifying and completing an initial business combination rather than ongoing products or services. In December 2022, Healthcare Services Acquisition Corporation announced its dissolution and liquidation due to failure to consummate a business combination within the required timeframe, redeeming all outstanding public shares at approximately $10.11 per share, cancelling the shares effective December 22, 2022, and proceeding with Nasdaq delisting via Form 25 and SEC deregistration via Form 15, with warrants expiring worthless.